Cognitive Neurology, Dementia, and Neurodegeneration
Cognition as Distributed Network Function
Cognitive Systems
Memory, language, attention, executive function, visuospatial ability, and social cognition depend on interacting cortical and subcortical systems. Dementia syndromes arise when neurodegenerative, vascular, inflammatory, toxic, or prion processes impair these networks.
Common Dementia Syndromes
Alzheimer disease
- Often begins with episodic memory impairment
- Linked to amyloid and tau pathology
- Biomarkers increasingly support in vivo diagnosis
Frontotemporal dementia
- Prominent behavioral or language dysfunction
- Often affects frontal and temporal networks
- Associated with several molecular subtypes
Biomarker Classes
A patient with prominent early behavioral disinhibition, loss of empathy, and executive dysfunction most likely has pathology affecting which region?
This profile strongly suggests frontotemporal network involvement.
Correct answer: Frontal and anterior temporal networks
What is one major limitation of purely symptom-based dementia diagnosis?
Phenotypes overlap, so biomarkers increasingly improve etiologic precision.
Correct answer: Different molecular diseases can produce similar clinical syndromes.
Modern Dementia Workup
-
1
Step 1: Establish the cognitive domain affected first and worst.
-
2
Step 2: Determine tempo, functional decline, and associated neurologic signs.
-
3
Step 3: Screen for reversible contributors and vascular burden.
-
4
Step 4: Use MRI, PET, CSF, or blood biomarkers to refine etiology.
-
5
Step 5: Match therapy to pathology when possible.
Which biomarker category is most directly associated with neuronal injury rather than a specific protein aggregate?
Neurodegeneration markers reflect injury or loss more generally, not just a single aggregate pathology.
Correct answer: Neurodegeneration markers
Open Questions
A major frontier is identifying disease-modifying interventions that intervene before symptomatic network failure, and determining how to combine fluid biomarkers, digital phenotyping, and imaging into predictive models of progression.